Clinical Trial Update: Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma [Phase 2]

View source ↗

Summary

A Phase 2 cross-over trial in adults with persistent asthma evaluating the effect of CHF 5188 inhaler on trough FEV1 after 4 weeks of once-daily treatment (comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CHF 5188 pMDI

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED